Overall impact
C (58)

Commentary

Sientra is an average overall performer. With a 'C' rating of 57.6 for overall impact (57th percentile compared to all companies), Sientra ranks 70th out of 103 industry peers, behind Waters, MyMD Pharmaceuticals, Alphatec and 66 others, and ahead of Envista Holdings, Mesa Laboratories, NeuroMetrix and 30 others. On top material causes for Sientra's industry (Healthcare Equipment), Sientra performs well in Child and Maternal Health (95.8 score) and Child and Maternal Health (93.2) and performs poorly in Disaster Readiness and Effective Aid (30.0 score), Technology Innovation (15.6) and Decent, Safe Work Opportunities (26.7).
Impact
Cause SIEN
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
304
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Supplies
SASB industry
Medical Equipment & Supplies
Headquarters
Ca, United States
Share classes
SIEN
Description
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; and saline filled sizers. It serves hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Material causes
Ethos considers the following causes material for Sientra, based on its industry sub-industry Health Care Supplies. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.